Log in to save to my catalogue

GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation

GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8087212

GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation

About this item

Full title

GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2021-05, Vol.131 (9), p.1-19

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

GDP-mannose-pyrophosphorylase-B (GMPPB) facilitates the generation of GDP-mannose, a sugar donor required for glycosylation. GMPPB defects cause muscle disease due to hypoglycosylation of α-dystroglycan (α-DG). Alpha-DG is part of a protein complex, which links the extracellular matrix with the cytoskeleton, thus stabilizing myofibers. Mutations of...

Alternative Titles

Full title

GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8087212

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8087212

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI139076

How to access this item